ALXO Aug 2024 11.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:26PM EDT. Market open.
| Previous close | 1.6500 |
| Open | 1.5500 |
| Bid | 0.7000 |
| Ask | 2.9000 |
| Strike | 11.00 |
| Expiry date | 2024-08-16 |
| Day's range | 1.5500 - 1.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | 45 |
ZacksDr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
Dr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop and commercialize the latter's biosimilar candidate, AVT03, to Prolia and Xgeva.
GuruFocus.comInsider Sale: Chief Medical Officer of ALX Oncology Holdings Inc (ALXO) Sells Shares
Sophia Randolph, Chief Medical Officer of ALX Oncology Holdings Inc (NASDAQ:ALXO), sold 12,000 shares of the company on May 13, 2024.
ZacksWall Street Analysts Think ALX Oncology Holdings (ALXO) Could Surge 36.64%: Read This Before Placing a Bet
The mean of analysts' price targets for ALX Oncology Holdings (ALXO) points to a 36.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
© 2024 Yahoo. All rights reserved.